Literature DB >> 20080162

Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.

S Zou1, K Scarfo, M H Nantz, J G Hecker.   

Abstract

The design of appropriate gene delivery systems is essential for the successful application of gene therapy to clinical medicine. Cationic lipid-mediated delivery is a viable alternative to viral vector-mediated gene delivery in applications where transient gene expression is desirable. However, cationic lipid-mediated delivery of DNA to post-mitotic cells such as neurons is often reported to be of low efficiency, due to the presumed inability of the DNA to translocate to the nucleus. Lipid-mediated delivery of RNA is an attractive alternative to non-viral DNA delivery in some clinical applications, because transit across the nuclear membrane is not necessary. Here we report a comparative investigation of cationic lipid-mediated delivery of RNA versus DNA vectors encoding the reporter gene green fluorescent protein (GFP) in Chinese Hamster Ovary (CHO) and NIH3T3 cells following chemical inhibition of proliferation, and in primary mixed neuronal cell cultures. Using optimized formulations and transfection procedures, we assess gene expression by flow cytometry to specifically address some of the advantages and disadvantages of lipid-mediated RNA and DNA gene transfer. Despite inhibition of cell proliferation, over 45% of CHO cells express GFP after lipid-mediated transfection with RNA vectors. Transfection efficiency of DNA encoding GFP in proliferation-inhibited CHO cells was less than 5%. Detectable expression after RNA transfection occurs at least 3h earlier than after DNA transfection, but DNA transfection eventually produces a mean level of per cell GFP expression (as assayed by flow cytometry) that is higher than after RNA transfection. Transfection of proliferation-inhibited NIH3T3 cells and primary mixed neuronal cultures produced similar results, with RNA encoded GFP expression in 2-4 times the number of cells as after DNA encoded GFP expression. These results demonstrate the increased efficiency of RNA transfection relative to DNA transfection in non-dividing cells. We used firefly luciferase encoded by RNA and DNA vectors to investigate the time course of gene expression after delivery of RNA or DNA to primary neuronal cortical cells. Delivery of mRNA resulted in rapid onset (within 1h) of luciferase expression after transfection, a peak in expression 5-7h after transfection, and a return to baseline within 12h after transfection. After DNA delivery significant luciferase activity did not appear until 7h after transfection, but peak luciferase expression was always at least one order of magnitude higher than after RNA delivery. The peak expression after luciferase-expressing DNA delivery occurred 36-48 h after transfection and remained at a significant level for at least one week before dropping to baseline. This observation is consistent with our in vivo delivery results, which are shown as well. RNA delivery may therefore be more suitable for short-term transient gene expression due to rapid onset, shorter duration of expression and greater efficiency, particularly in non-dividing cells. Higher mean levels of expression per cell obtained following DNA delivery and the longer duration of expression confirm a continuing role for DNA gene delivery in clinical applications that require longer term transient gene expression. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080162      PMCID: PMC2849731          DOI: 10.1016/j.ijpharm.2010.01.019

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  40 in total

1.  Atomic force microscopy imaging of DNA-cationic liposome complexes optimised for gene transfection into neuronal cells.

Authors:  L A Wangerek; H H Dahl; T J Senden; J B Carlin; D A Jans; D E Dunstan; P A Ioannou; R Williamson; S M Forrest
Journal:  J Gene Med       Date:  2001 Jan-Feb       Impact factor: 4.565

2.  Biological barriers to cellular delivery of lipid-based DNA carriers.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-08-20       Impact factor: 15.470

3.  Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells.

Authors:  Jolene M Ignowski; David V Schaffer
Journal:  Biotechnol Bioeng       Date:  2004-06-30       Impact factor: 4.530

4.  In vivo protein expression from mRNA delivered into adult rat brain.

Authors:  K Karikó; J M Keller; V A Harris; D J Langer; F A Welsh
Journal:  J Neurosci Methods       Date:  2001-01-30       Impact factor: 2.390

Review 5.  Nucleocytoplasmic transport: the soluble phase.

Authors:  I W Mattaj; L Englmeier
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

6.  HSP101 functions as a specific translational regulatory protein whose activity is regulated by nutrient status.

Authors:  D R Wells; R L Tanguay; H Le; D R Gallie
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

Review 7.  Two-way trafficking with Ran.

Authors:  F Melchior; L Gerace
Journal:  Trends Cell Biol       Date:  1998-05       Impact factor: 20.808

Review 8.  Gene therapy: the first two decades and the current state-of-the-art.

Authors:  Terence R Flotte
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

9.  Cellular and molecular barriers to gene transfer by a cationic lipid.

Authors:  J Zabner; A J Fasbender; T Moninger; K A Poellinger; M J Welsh
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

10.  Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system.

Authors:  Dua M Anderson; Leon L Hall; Anitha R Ayyalapu; Van R Irion; Michael H Nantz; James G Hecker
Journal:  Hum Gene Ther       Date:  2003-02-10       Impact factor: 5.695

View more
  51 in total

1.  Structurally Programmed Assembly of Translation Initiation Nanoplex for Superior mRNA Delivery.

Authors:  Jiahe Li; Wade Wang; Yanpu He; Yingzhong Li; Emily Z Yan; Ketian Zhang; Darrell J Irvine; Paula T Hammond
Journal:  ACS Nano       Date:  2017-02-14       Impact factor: 15.881

Review 2.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.

Authors:  S Guan; J Rosenecker
Journal:  Gene Ther       Date:  2017-01-17       Impact factor: 5.250

3.  Easy In Vitro Synthesis of Optimised Functioning Reporter mRNA from Common eGFP Plasmid.

Authors:  Gustavo Torres de Souza; Rafaela Chitarra Rodrigues Hell; Jéssica Fernanda da Silva Souza; Luiz Sérgio de Almeida Camargo
Journal:  Mol Biotechnol       Date:  2018-10       Impact factor: 2.695

4.  A single intrathecal injection of DNA and an asymmetric cationic lipid as lipoplexes ameliorates experimental autoimmune encephalomyelitis.

Authors:  Srikanth Yellayi; Brendan Hilliard; Mustafa Ghazanfar; Akivaga Tsingalia; Michael H Nantz; Laura Bollinger; Fabian de Kok-Mercado; James G Hecker
Journal:  Mol Pharm       Date:  2011-07-19       Impact factor: 4.939

5.  Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression.

Authors:  Irene C Turnbull; Ahmed A Eltoukhy; Kenneth M Fish; Mathieu Nonnenmacher; Kiyotake Ishikawa; Jiqiu Chen; Roger J Hajjar; Daniel G Anderson; Kevin D Costa
Journal:  Mol Ther       Date:  2015-10-16       Impact factor: 11.454

Review 6.  Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications.

Authors:  Siddharth Patel; Avathamsa Athirasala; Paula P Menezes; N Ashwanikumar; Ting Zou; Gaurav Sahay; Luiz E Bertassoni
Journal:  Tissue Eng Part A       Date:  2018-06-07       Impact factor: 3.845

7.  A method for stabilizing RNA for transfection that allows control of expression duration.

Authors:  Toshinori Hayashi; Deepak A Lamba; Amber Slowik; Thomas A Reh; Olivia Bermingham-McDonogh
Journal:  Dev Dyn       Date:  2010-07       Impact factor: 3.780

8.  Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA.

Authors:  Siddharth Patel; N Ashwanikumar; Emily Robinson; Allison DuRoss; Conroy Sun; Kerry E Murphy-Benenato; Cosmin Mihai; Örn Almarsson; Gaurav Sahay
Journal:  Nano Lett       Date:  2017-08-24       Impact factor: 11.189

Review 9.  Messenger RNA (mRNA) nanoparticle tumour vaccination.

Authors:  Kyle K L Phua; Smita K Nair; Kam W Leong
Journal:  Nanoscale       Date:  2014-07-21       Impact factor: 7.790

10.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.